Finally, by using NSCLC in vitro and in vivo models, Skavatsou et al. demonstrated that exposure to combined gemcitabine and anti PD-1 mAb up-regulated the expression of TSP-1 and VEGF-A, thus restricting tumor angiogenesis. This evidence concerns the gene THBS1 and neoplasm.